{"disease":{"id":"recurrent-meningioma","name":"recurrent meningioma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04427384","title":"Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"GT Medical Technologies, Inc.","has_results":false},{"nct_id":"NCT06326190","title":"177Lu-DOTATATE for Recurrent Meningioma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":136,"lead_sponsor_name":"European Organisation for Research and Treatment of Cancer - EORTC","has_results":false},{"nct_id":"NCT06739213","title":"A Phase II Study of SYHA1813 for Recurrent or Progressive High-Grade Meningioma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":56,"lead_sponsor_name":"Shanghai Runshi Pharmaceutical Technology Co., Ltd","has_results":false},{"nct_id":"NCT04082520","title":"Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":41,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT04239092","title":"9-ING-41 in Pediatric Patients With Refractory Malignancies.","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":40,"lead_sponsor_name":"Actuate Therapeutics Inc.","has_results":false},{"nct_id":"NCT03604978","title":"Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":38,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04659811","title":"Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":35,"lead_sponsor_name":"Nancy Ann Oberheim Bush, MD","has_results":false},{"nct_id":"NCT07150806","title":"RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma","phase":"PHASE1, PHASE2","overall_status":"SUSPENDED","enrollment_count":30,"lead_sponsor_name":"Joshua Palmer","has_results":false},{"nct_id":"NCT05023018","title":"NEO100 and High-Grade Meningioma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Neonc Technologies, Inc.","has_results":false},{"nct_id":"NCT04501705","title":"Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults","phase":"NA","overall_status":"RECRUITING","enrollment_count":29,"lead_sponsor_name":"Beijing Sanbo Brain Hospital","has_results":false},{"nct_id":"NCT06557512","title":"Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma","phase":"NA","overall_status":"RECRUITING","enrollment_count":23,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT02333565","title":"Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Assistance Publique Hopitaux De Marseille","has_results":false},{"nct_id":"NCT06322342","title":"Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Reveal Pharmaceuticals Inc.","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}